Inventor · disambiguated record
Munehisa Yabuki
Also filed as: YABUKI MUNEHISA
15 granted patents·9 pending applications·40 citations·filing 2008–2024
90Inventor score
Top patents by PatentIndex Score
24 records- 0192US10745274B1Nucleic acids encoding antibodies specifically binding to MASP-3OMEROS CORP·Filed 2020·Granted Aug 18, 2020·2 cites·13 claims
- 0289US12091468B2Therapeutic antibodies that bind to the serine protease domain of MASP-2 and uses thereofOMEROS CORP·Filed 2023·Granted Sep 17, 2024·1 cites·18 claims
- 0388US11883493B2Antibodies specifically binding to MASP-3 for the treatment of various diseases and disordersOMEROS CORP·Filed 2021·Granted Jan 30, 2024·1 cites·17 claims
- 0487US11027015B2Antibodies specifically binding to MASP-3 for the treatment of various diseases and disordersOMEROS CORP·Filed 2020·Granted Jun 8, 2021·1 cites·19 claims
- 0587US2024342278A1Antibodies specifically binding to masp-3 for the treatment of various diseases and disordersOMEROS CORP·Filed 2023·Application pending·0 cites
- 0686US9273119B2Inducible mutagenesis of target genesUNIV WASHINGTON·Filed 2014·Granted Mar 1, 2016·5 cites·16 claims
- 0785US9677070B2Composition and method for diversification of target sequencesOMEROS CORP·Filed 2013·Granted Jun 13, 2017·6 cites·28 claims
- 0885US9102724B2Anti-FZD10 monoclonal antibodies and methods for their useCUMMINGS W JASON·Filed 2012·Granted Aug 11, 2015·15 cites·19 claims
- 0982US10639369B2Antibodies specifically binding to MASP-3 for the treatment of various diseases and disordersOMEROS CORP·Filed 2017·Granted May 5, 2020·2 cites·30 claims
- 1081US2025122309A1Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the SameOMEROS CORP·Filed 2024·Application pending·0 cites
- 1177US11045544B2Methods of generating bioactive peptide-bearing antibodies and compositions comprising the sameOMEROS CORP·Filed 2017·Granted Jun 29, 2021·1 cites·2 claims
- 1276US8679845B2B cells modified to reversibly induce accelerated mutagenesis of target genesMAIZELS NANCY·Filed 2008·Granted Mar 25, 2014·3 cites·31 claims
- 1371US8609818B2Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolutionLEPPARD JOHN BENJAMIN·Filed 2012·Granted Dec 17, 2013·2 cites·38 claims
- 1470US2025179160A1Monoclonal antibodies, compositions and methods for detecting complement factor dOMEROS CORP·Filed 2024·Application pending·0 cites
- 1569US9346888B2Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolutionOMEROS CORP·Filed 2013·Granted May 24, 2016·1 cites·20 claims
- 1666US2023265215A1Therapeutic antibodies that bind to the serine protease domain of masp-2 and uses thereofOMEROS CORP·Filed 2022·Application pending·0 cites
- 1765US2021079117A1Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the SameOMEROS CORP·Filed 2020·Application pending·0 cites
- 1862US2023173091A1Targeted catalytic complement-activating molecules and methods of use thereofOMEROS CORP·Filed 2022·Application pending·0 cites
- 1960US12129290B2Monoclonal antibodies, compositions and methods for detecting complement factor DOMEROS CORP·Filed 2021·Granted Oct 29, 2024·0 cites·33 claims
- 2059US9815885B2Inducible mutagenesis of target genesUNIV WASHINGTON·Filed 2015·Granted Nov 14, 2017·0 cites·15 claims
- 2157US2015017162A1Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the SameOMEROS CORP·Filed 2014·Application pending·0 cites
- 2256US2022308056A1Biomarker for assessing the risk of developing acute covid-19 and post-acute covid-19OMEROS CORP·Filed 2022·Application pending·0 cites
- 2355US2014363433A1Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the SameOMEROS CORP·Filed 2014·Application pending·0 cites
- 2442US9777065B2Anti-FZD10 monoclonal antibodies and methods for their useOMEROS CORP·Filed 2015·Granted Oct 3, 2017·0 cites·25 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →